|
End-of-day quote
Nasdaq Stockholm
2026-09-11
|
5-day change | 1st Jan Change | ||
| 16.75 SEK | -7.20% |
|
-11.14% | -51.45% |
| 09-09 | Calendar Wednesday, September 9 | FW |
| 09-08 | SciBase Holding AB Receives Additional Order From Castle Biosciences Inc | CI |
Company Valuation: SciBase Holding AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 378 | 261.6 | 99.94 | 90.01 | 142.9 | 171.3 | - | - |
| Change | - | -30.8% | -61.79% | -9.93% | 58.75% | 19.86% | - | - |
| Enterprise Value (EV) | 378 | 248 | 70 | 80.34 | 142.9 | 171.3 | 171.3 | 171.3 |
| Change | - | -34.4% | -71.77% | 14.77% | 77.87% | 19.86% | 0% | 0% |
| P/E | -8.24x | -6.06x | -1.64x | -1.21x | - | - | - | - |
| PBR | - | - | 2.32x | - | - | - | - | - |
| PEG | - | 1.02x | 0.1x | 0x | - | - | - | - |
| Capitalization / Revenue | - | 14.6x | 4.3x | 3.03x | 3.53x | 2.81x | 1.75x | 1.18x |
| EV / Revenue | - | 0x | 0x | 0x | 0x | 2.81x | 1.75x | 1.18x |
| EV / EBITDA | - | -0x | -0x | -0x | -0x | -1.84x | -2.64x | -4.73x |
| EV / EBIT | - | -0x | -0x | -0x | -0x | -1.76x | -2.46x | -4.11x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -67 | -63 | -51 | -34 | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | 17.89 | 23.24 | 29.7 | 40.46 | 60.9 | 97.7 | 144.9 |
| EBITDA 1 | - | -42.77 | -50.55 | -63.94 | -82.72 | -93.1 | -64.8 | -36.2 |
| EBIT 1 | - | -46.42 | -53.94 | -67.17 | -86.41 | -97.4 | -69.7 | -41.7 |
| Net income 1 | -41.78 | -43.17 | -55.58 | -61.12 | -87.06 | -97.5 | -69.7 | - |
| Net Debt | - | -13.62 | -29.94 | -9.675 | - | - | - | - |
| Reference price 2 | 552.00 | 382.00 | 83.40 | 41.00 | 34.50 | 16.75 | 16.75 | 16.75 |
| Nbr of stocks (in thousands) | 685 | 685 | 1,198 | 2,195 | 4,142 | 10,225 | - | - |
| Announcement Date | 4/22/22 | 2/13/23 | 2/21/24 | 2/25/25 | 3/13/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 19.1M | |
| 60.55x | 4.81x | 16.07x | 0.35% | 16.65B | |
| 41.19x | - | - | 1.96% | 1.78B | |
| 15.02x | 2.05x | 6.97x | 1.71% | 894M | |
| -2.95x | 1.39x | 6.45x | - | 833M | |
| 39.3x | - | - | - | 778M | |
| 121.03x | - | - | 0.97% | 591M | |
| 32.25x | 2.78x | 16.58x | -.--% | 436M | |
| -9.52x | - | - | - | 386M | |
| Average | 37.11x | 2.76x | 11.52x | 1% | 2.49B | |
| Weighted average by Cap. | 53.92x | 4.48x | 15.23x | 0.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SCIB Stock
- Valuation SciBase Holding AB
Select your edition
All financial news and data tailored to specific country editions
